Purpose

This randomized phase III trial is studying different combination chemotherapy regimens and comparing how well they work in treating patients with newly diagnosed acute lymphoblastic leukemia. Drugs used in chemotherapy work in different ways to stop the growth of cancer cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more cancer cells.

Category

IRB Number
20050285HU
NCT Number
-
Open to Enrollment
Yes
Sponsor
Children's Oncology Group -



Study Contact

Principal Investigator
Janice Marceaux

Regulatory Point of Contact
Janice Marceaux
janice.marceaux@va.gov

Regulatory Point of Contact
Janice Marceaux
janice23@uab.edu



Eligibility

Eligible Ages
Between 1 Year and 9 Years
Eligible Genders
All
Accepts Healthy Volunteers
No

Inclusion Criteria

    Exclusion Criteria


      Study Design

      Arm Groups